Cargando…

Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?

Detalles Bibliográficos
Autores principales:	Lo Muzio, Lorenzo, Spirito, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society of Global Health 2022
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107288/ https://www.ncbi.nlm.nih.gov/pubmed/35567581 http://dx.doi.org/10.7189/jogh.12.03023

Ejemplares similares

Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2021)

Marketing SARS-CoV-2 Vaccines: an Opportunity to Test a Nobel Prize–Winning Theory
por: Verma, Amol A., et al.
Publicado: (2021)

SARS-CoV-2 Infection and Taste Alteration: An Overview
por: Scotto, Gaetano, et al.
Publicado: (2022)

CRISPR Pioneers Win 2020 Nobel Prize for Chemistry
por: FARHUD, Dariush D., et al.
Publicado: (2020)

A focus on the spread of the delta variant of SARS-CoV-2 in India
por: Novelli, Giuseppe, et al.
Publicado: (2021)

Could the Biogeographic Background Affect the Emergence of SARS-CoV-2 Variants?
por: Akaishi, Tetsuya
Publicado: (2022)

Cancer and War in Ukraine: How the World Can Help Win This Battle
por: Kozhukhov, Sergey, et al.
Publicado: (2022)

Beyond winning: mediation, conflict resolution, and non-rational sources of conflict in the ICU
por: Knickle, Kerry, et al.
Publicado: (2012)

Tracking Insecticide Resistance in Mosquito Vectors of Arboviruses: The Worldwide Insecticide resistance Network (WIN)
por: Corbel, Vincent, et al.
Publicado: (2016)

The ‘triple win’ practice: the importance of organizational support for volunteer endeavors undertaken by health care professionals and staff
por: Logan, Dilani, et al.
Publicado: (2018)

Estimating the seroprevalence of SARS-CoV-2 antibodies: Understanding population-level immunity in Albania at the end of the Alpha variant wave
por: Cenko, Fabian, et al.
Publicado: (2022)

Epidemiological profiles of SARS-CoV and SARS-Cov-2 in Singapore and its promising containment strategies
por: Chaturvedi, Rini, et al.
Publicado: (2021)

Systematic Development of the ReWin Application: A Digital Therapeutic Rehabilitation Innovation for People With Stroke-related Disabilities in India
por: Kamalakannan, Sureshkumar, et al.
Publicado: (2022)

The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line
por: Manikandan, S.
Publicado: (2023)

Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease?
por: Muller, Claude P.
Publicado: (2021)

Skirt Flap for Nasal Alar Reconstruction
por: Ueda, Koichi, et al.
Publicado: (2014)

A viewpoint: The 2022 monkeypox outbreak
por: Simões, Pedro, et al.
Publicado: (2022)

Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities
por: Esposito, Susanna, et al.
Publicado: (2021)

Engineering monoclonal antibodies for COVID-19 prophylaxis
por: Izadpanah, Amin, et al.
Publicado: (2022)

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term
por: Jankowitz, Rachel C, et al.
Publicado: (2012)

Influencing factors of SARS-Cov2 spread in Africa
por: Admou, Brahim, et al.
Publicado: (2020)

SARS-CoV-2: The Second Wave in Europe
por: Fokas, Athanassios S, et al.
Publicado: (2021)

HIV vaccines in 2022: where to from here?
por: Hannah, Stacey, et al.
Publicado: (2022)

SARS-CoV-2 vaccine development, access, and equity
por: Kim, Jerome H.
Publicado: (2020)

Human-Animal Interaction and the Emergence of SARS-CoV-2
por: Hassani, Asma, et al.
Publicado: (2020)

Schrödinger’s Worker: Are They Positive or Negative for SARS-CoV-2?
por: Meloni, Federico, et al.
Publicado: (2020)

Tumor markers as an entry for SARS‐CoV‐2 infection?
por: Xia, Pu, et al.
Publicado: (2020)

Wearables in the SARS-CoV-2 Pandemic: What Are They Good for?
por: Bent, Brinnae, et al.
Publicado: (2020)

Which low‐dose atropine for myopia control?
por: Khanal, Safal, et al.
Publicado: (2019)

Biological Spare Part Surgery Applied to Nasal Reconstruction
por: Lee, Shu Jin, et al.
Publicado: (2016)

Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension
por: Manzi, Giovanna, et al.
Publicado: (2022)

Can Robots Improve Testing Capacity for SARS-CoV-2?
por: Cresswell, Kathrin, et al.
Publicado: (2020)

Reducing Aerosol Transmission of SARS-CoV-2 in Craniomaxillofacial Osteosynthesis
por: Arakeri, Gururaj, et al.
Publicado: (2020)

In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease
por: Epelbaum, Oleg, et al.
Publicado: (2020)

Targeting neuropilins as a viable SARS‐CoV‐2 treatment
por: Sarabipour, Sarvenaz, et al.
Publicado: (2021)

Global variation in sequencing impedes SARS-CoV-2 surveillance
por: Crawford, Dana C., et al.
Publicado: (2021)

Recommendations for return to sport during the SARS-CoV-2 pandemic
por: Löllgen, Herbert, et al.
Publicado: (2020)

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
por: Glebov, Oleg O.
Publicado: (2020)

Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection
por: Thapa, Bibechan
Publicado: (2021)

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
por: Oliu-Barton, Miquel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eoemf6cim9vpfr4snpkp5tpdot